nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—SCN10A—skin cancer	0.58	1	CbGaD
Mexiletine—CYP1A2—Imiquimod—skin cancer	0.0605	0.193	CbGbCtD
Mexiletine—CYP2E1—Dacarbazine—skin cancer	0.0439	0.14	CbGbCtD
Mexiletine—CYP1A2—Vemurafenib—skin cancer	0.0331	0.106	CbGbCtD
Mexiletine—CYP3A4—Imiquimod—skin cancer	0.0317	0.101	CbGbCtD
Mexiletine—CYP3A4—Temozolomide—skin cancer	0.0317	0.101	CbGbCtD
Mexiletine—CYP2D6—Vemurafenib—skin cancer	0.0273	0.087	CbGbCtD
Mexiletine—CYP1A2—Dacarbazine—skin cancer	0.0254	0.0809	CbGbCtD
Mexiletine—CYP3A4—Vismodegib—skin cancer	0.022	0.07	CbGbCtD
Mexiletine—CYP3A4—Vemurafenib—skin cancer	0.0174	0.0553	CbGbCtD
Mexiletine—CYP1A2—Fluorouracil—skin cancer	0.0149	0.0475	CbGbCtD
Mexiletine—CYP3A4—Docetaxel—skin cancer	0.00596	0.019	CbGbCtD
Mexiletine—Tocainide—SCN10A—skin cancer	0.00329	1	CrCbGaD
Mexiletine—SCN9A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00126	0.0947	CbGpPWpGaD
Mexiletine—SCN2A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00116	0.087	CbGpPWpGaD
Mexiletine—SCN4A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00116	0.087	CbGpPWpGaD
Mexiletine—AHR—Adipogenesis—ASIP—skin cancer	0.000987	0.0741	CbGpPWpGaD
Mexiletine—SCN5A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.000786	0.059	CbGpPWpGaD
Mexiletine—AHR—Adipogenesis—PLIN2—skin cancer	0.000598	0.0449	CbGpPWpGaD
Mexiletine—SCN9A—L1CAM interactions—SCN10A—skin cancer	0.000484	0.0363	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—XRCC3—skin cancer	0.00048	0.036	CbGpPWpGaD
Mexiletine—SCN4A—L1CAM interactions—SCN10A—skin cancer	0.000445	0.0334	CbGpPWpGaD
Mexiletine—SCN2A—L1CAM interactions—SCN10A—skin cancer	0.000445	0.0334	CbGpPWpGaD
Mexiletine—Alopecia—Imiquimod—skin cancer	0.000433	0.0048	CcSEcCtD
Mexiletine—Arthralgia—Vemurafenib—skin cancer	0.000425	0.00472	CcSEcCtD
Mexiletine—Vomiting—Vismodegib—skin cancer	0.00042	0.00465	CcSEcCtD
Mexiletine—Rash—Vismodegib—skin cancer	0.000416	0.00462	CcSEcCtD
Mexiletine—Amnesia—Fluorouracil—skin cancer	0.000416	0.00461	CcSEcCtD
Mexiletine—Dermatitis—Vismodegib—skin cancer	0.000416	0.00461	CcSEcCtD
Mexiletine—Dysphagia—Dactinomycin—skin cancer	0.000405	0.00449	CcSEcCtD
Mexiletine—AHR—Circadian rythm related genes—NKX2-1—skin cancer	0.0004	0.03	CbGpPWpGaD
Mexiletine—Ataxia—Temozolomide—skin cancer	0.000399	0.00442	CcSEcCtD
Mexiletine—Ill-defined disorder—Imiquimod—skin cancer	0.000395	0.00438	CcSEcCtD
Mexiletine—Nausea—Vismodegib—skin cancer	0.000392	0.00435	CcSEcCtD
Mexiletine—Dry skin—Temozolomide—skin cancer	0.000389	0.00431	CcSEcCtD
Mexiletine—Malaise—Imiquimod—skin cancer	0.000384	0.00426	CcSEcCtD
Mexiletine—Syncope—Imiquimod—skin cancer	0.000382	0.00424	CcSEcCtD
Mexiletine—Hypotension—Vemurafenib—skin cancer	0.000381	0.00423	CcSEcCtD
Mexiletine—Neutropenia—Dactinomycin—skin cancer	0.000379	0.0042	CcSEcCtD
Mexiletine—Palpitations—Imiquimod—skin cancer	0.000377	0.00418	CcSEcCtD
Mexiletine—Loss of consciousness—Imiquimod—skin cancer	0.000375	0.00415	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000372	0.00412	CcSEcCtD
Mexiletine—Convulsion—Imiquimod—skin cancer	0.000369	0.00409	CcSEcCtD
Mexiletine—Hypertension—Imiquimod—skin cancer	0.000368	0.00408	CcSEcCtD
Mexiletine—Ataxia—Fluorouracil—skin cancer	0.000367	0.00407	CcSEcCtD
Mexiletine—Dysphagia—Temozolomide—skin cancer	0.000366	0.00406	CcSEcCtD
Mexiletine—Arthralgia—Imiquimod—skin cancer	0.000363	0.00402	CcSEcCtD
Mexiletine—Chest pain—Imiquimod—skin cancer	0.000363	0.00402	CcSEcCtD
Mexiletine—Discomfort—Imiquimod—skin cancer	0.000358	0.00397	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000358	0.00397	CcSEcCtD
Mexiletine—Dry skin—Fluorouracil—skin cancer	0.000358	0.00397	CcSEcCtD
Mexiletine—Sweating increased—Temozolomide—skin cancer	0.000357	0.00396	CcSEcCtD
Mexiletine—Dry mouth—Imiquimod—skin cancer	0.000355	0.00393	CcSEcCtD
Mexiletine—Fatigue—Vemurafenib—skin cancer	0.000352	0.0039	CcSEcCtD
Mexiletine—Constipation—Vemurafenib—skin cancer	0.000349	0.00387	CcSEcCtD
Mexiletine—Oedema—Imiquimod—skin cancer	0.000348	0.00386	CcSEcCtD
Mexiletine—Lightheadedness—Docetaxel—skin cancer	0.000348	0.00385	CcSEcCtD
Mexiletine—Hypoaesthesia—Bleomycin—skin cancer	0.000346	0.00384	CcSEcCtD
Mexiletine—Neutropenia—Temozolomide—skin cancer	0.000343	0.0038	CcSEcCtD
Mexiletine—Shock—Imiquimod—skin cancer	0.000342	0.00379	CcSEcCtD
Mexiletine—Dysphagia—Fluorouracil—skin cancer	0.000338	0.00374	CcSEcCtD
Mexiletine—Erectile dysfunction—Temozolomide—skin cancer	0.000338	0.00374	CcSEcCtD
Mexiletine—Agranulocytosis—Dactinomycin—skin cancer	0.000337	0.00374	CcSEcCtD
Mexiletine—Hyperhidrosis—Imiquimod—skin cancer	0.000336	0.00373	CcSEcCtD
Mexiletine—Angina pectoris—Fluorouracil—skin cancer	0.000329	0.00365	CcSEcCtD
Mexiletine—Depression—Temozolomide—skin cancer	0.000326	0.00361	CcSEcCtD
Mexiletine—Hepatitis—Dactinomycin—skin cancer	0.000324	0.0036	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000324	0.00359	CcSEcCtD
Mexiletine—Body temperature increased—Vemurafenib—skin cancer	0.000322	0.00357	CcSEcCtD
Mexiletine—Pharyngitis—Dactinomycin—skin cancer	0.000322	0.00357	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000317	0.00351	CcSEcCtD
Mexiletine—Paraesthesia—Imiquimod—skin cancer	0.000312	0.00346	CcSEcCtD
Mexiletine—Cardiac failure congestive—Docetaxel—skin cancer	0.000311	0.00345	CcSEcCtD
Mexiletine—Dyspnoea—Imiquimod—skin cancer	0.00031	0.00344	CcSEcCtD
Mexiletine—Somnolence—Imiquimod—skin cancer	0.000309	0.00343	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—MSH2—skin cancer	0.000309	0.0232	CbGpPWpGaD
Mexiletine—Alopecia—Bleomycin—skin cancer	0.000307	0.00341	CcSEcCtD
Mexiletine—Erythema multiforme—Dactinomycin—skin cancer	0.000307	0.0034	CcSEcCtD
Mexiletine—Dyspepsia—Imiquimod—skin cancer	0.000306	0.00339	CcSEcCtD
Mexiletine—SCN5A—L1CAM interactions—SCN10A—skin cancer	0.000302	0.0226	CbGpPWpGaD
Mexiletine—Hot flush—Docetaxel—skin cancer	0.000301	0.00334	CcSEcCtD
Mexiletine—Hypersensitivity—Vemurafenib—skin cancer	0.0003	0.00333	CcSEcCtD
Mexiletine—Fatigue—Imiquimod—skin cancer	0.0003	0.00332	CcSEcCtD
Mexiletine—Menopausal symptoms—Docetaxel—skin cancer	0.000299	0.00331	CcSEcCtD
Mexiletine—Visual disturbance—Docetaxel—skin cancer	0.000298	0.0033	CcSEcCtD
Mexiletine—Pain—Imiquimod—skin cancer	0.000297	0.0033	CcSEcCtD
Mexiletine—Hepatitis—Temozolomide—skin cancer	0.000293	0.00325	CcSEcCtD
Mexiletine—Asthenia—Vemurafenib—skin cancer	0.000293	0.00324	CcSEcCtD
Mexiletine—Hallucination—Temozolomide—skin cancer	0.000292	0.00324	CcSEcCtD
Mexiletine—Hypoaesthesia—Temozolomide—skin cancer	0.000292	0.00324	CcSEcCtD
Mexiletine—Pharyngitis—Temozolomide—skin cancer	0.000291	0.00323	CcSEcCtD
Mexiletine—Alopecia—Dactinomycin—skin cancer	0.000287	0.00318	CcSEcCtD
Mexiletine—Feeling abnormal—Imiquimod—skin cancer	0.000287	0.00318	CcSEcCtD
Mexiletine—Gastrointestinal pain—Imiquimod—skin cancer	0.000284	0.00315	CcSEcCtD
Mexiletine—Visual impairment—Temozolomide—skin cancer	0.000283	0.00313	CcSEcCtD
Mexiletine—Agranulocytosis—Fluorouracil—skin cancer	0.000281	0.00312	CcSEcCtD
Mexiletine—Ill-defined disorder—Bleomycin—skin cancer	0.000281	0.00311	CcSEcCtD
Mexiletine—Diarrhoea—Vemurafenib—skin cancer	0.000279	0.00309	CcSEcCtD
Mexiletine—Erythema multiforme—Temozolomide—skin cancer	0.000277	0.00308	CcSEcCtD
Mexiletine—Body temperature increased—Imiquimod—skin cancer	0.000275	0.00305	CcSEcCtD
Mexiletine—Abdominal pain—Imiquimod—skin cancer	0.000275	0.00305	CcSEcCtD
Mexiletine—Tinnitus—Temozolomide—skin cancer	0.000273	0.00303	CcSEcCtD
Mexiletine—Malaise—Bleomycin—skin cancer	0.000273	0.00303	CcSEcCtD
Mexiletine—Leukopenia—Bleomycin—skin cancer	0.000271	0.003	CcSEcCtD
Mexiletine—Dizziness—Vemurafenib—skin cancer	0.00027	0.00299	CcSEcCtD
Mexiletine—Hypoaesthesia—Fluorouracil—skin cancer	0.000269	0.00298	CcSEcCtD
Mexiletine—Pharyngitis—Fluorouracil—skin cancer	0.000268	0.00297	CcSEcCtD
Mexiletine—Ataxia—Docetaxel—skin cancer	0.000265	0.00294	CcSEcCtD
Mexiletine—Ill-defined disorder—Dactinomycin—skin cancer	0.000262	0.0029	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	0.000262	0.0197	CbGpPWpGaD
Mexiletine—Liver function test abnormal—Docetaxel—skin cancer	0.00026	0.00289	CcSEcCtD
Mexiletine—Vomiting—Vemurafenib—skin cancer	0.000259	0.00288	CcSEcCtD
Mexiletine—Alopecia—Temozolomide—skin cancer	0.000259	0.00287	CcSEcCtD
Mexiletine—Dry skin—Docetaxel—skin cancer	0.000258	0.00287	CcSEcCtD
Mexiletine—Chest pain—Bleomycin—skin cancer	0.000258	0.00286	CcSEcCtD
Mexiletine—Rash—Vemurafenib—skin cancer	0.000257	0.00285	CcSEcCtD
Mexiletine—Dermatitis—Vemurafenib—skin cancer	0.000257	0.00285	CcSEcCtD
Mexiletine—Hypersensitivity—Imiquimod—skin cancer	0.000256	0.00284	CcSEcCtD
Mexiletine—Headache—Vemurafenib—skin cancer	0.000255	0.00283	CcSEcCtD
Mexiletine—Discomfort—Bleomycin—skin cancer	0.000255	0.00282	CcSEcCtD
Mexiletine—Malaise—Dactinomycin—skin cancer	0.000255	0.00282	CcSEcCtD
Mexiletine—Cramp muscle—Docetaxel—skin cancer	0.000254	0.00282	CcSEcCtD
Mexiletine—Leukopenia—Dactinomycin—skin cancer	0.000253	0.0028	CcSEcCtD
Mexiletine—Dysgeusia—Temozolomide—skin cancer	0.00025	0.00277	CcSEcCtD
Mexiletine—Asthenia—Imiquimod—skin cancer	0.00025	0.00277	CcSEcCtD
Mexiletine—Confusional state—Bleomycin—skin cancer	0.000249	0.00276	CcSEcCtD
Mexiletine—Oedema—Bleomycin—skin cancer	0.000247	0.00274	CcSEcCtD
Mexiletine—Dysphagia—Docetaxel—skin cancer	0.000244	0.0027	CcSEcCtD
Mexiletine—Nausea—Vemurafenib—skin cancer	0.000242	0.00269	CcSEcCtD
Mexiletine—Thrombocytopenia—Bleomycin—skin cancer	0.000242	0.00268	CcSEcCtD
Mexiletine—Arrhythmia—Fluorouracil—skin cancer	0.000241	0.00268	CcSEcCtD
Mexiletine—Vision blurred—Temozolomide—skin cancer	0.000241	0.00267	CcSEcCtD
Mexiletine—Tremor—Temozolomide—skin cancer	0.000239	0.00265	CcSEcCtD
Mexiletine—Alopecia—Fluorouracil—skin cancer	0.000239	0.00265	CcSEcCtD
Mexiletine—Diarrhoea—Imiquimod—skin cancer	0.000238	0.00264	CcSEcCtD
Mexiletine—Discomfort—Dactinomycin—skin cancer	0.000237	0.00263	CcSEcCtD
Mexiletine—Angina pectoris—Docetaxel—skin cancer	0.000237	0.00263	CcSEcCtD
Mexiletine—Ill-defined disorder—Temozolomide—skin cancer	0.000237	0.00263	CcSEcCtD
Mexiletine—Hypotension—Bleomycin—skin cancer	0.000231	0.00256	CcSEcCtD
Mexiletine—Oedema—Dactinomycin—skin cancer	0.00023	0.00256	CcSEcCtD
Mexiletine—Malaise—Temozolomide—skin cancer	0.00023	0.00255	CcSEcCtD
Mexiletine—Dizziness—Imiquimod—skin cancer	0.00023	0.00255	CcSEcCtD
Mexiletine—Leukopenia—Temozolomide—skin cancer	0.000229	0.00253	CcSEcCtD
Mexiletine—Neutropenia—Docetaxel—skin cancer	0.000228	0.00253	CcSEcCtD
Mexiletine—Palpitations—Temozolomide—skin cancer	0.000226	0.0025	CcSEcCtD
Mexiletine—Thrombocytopenia—Dactinomycin—skin cancer	0.000226	0.0025	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000225	0.0025	CcSEcCtD
Mexiletine—Paraesthesia—Bleomycin—skin cancer	0.000222	0.00246	CcSEcCtD
Mexiletine—Vision blurred—Fluorouracil—skin cancer	0.000222	0.00246	CcSEcCtD
Mexiletine—Convulsion—Temozolomide—skin cancer	0.000221	0.00245	CcSEcCtD
Mexiletine—Vomiting—Imiquimod—skin cancer	0.000221	0.00245	CcSEcCtD
Mexiletine—Hypertension—Temozolomide—skin cancer	0.00022	0.00244	CcSEcCtD
Mexiletine—Dyspnoea—Bleomycin—skin cancer	0.00022	0.00244	CcSEcCtD
Mexiletine—Rash—Imiquimod—skin cancer	0.000219	0.00243	CcSEcCtD
Mexiletine—Dermatitis—Imiquimod—skin cancer	0.000219	0.00243	CcSEcCtD
Mexiletine—Headache—Imiquimod—skin cancer	0.000218	0.00242	CcSEcCtD
Mexiletine—Arthralgia—Temozolomide—skin cancer	0.000217	0.00241	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000215	0.00239	CcSEcCtD
Mexiletine—Discomfort—Temozolomide—skin cancer	0.000215	0.00238	CcSEcCtD
Mexiletine—Dry mouth—Temozolomide—skin cancer	0.000213	0.00236	CcSEcCtD
Mexiletine—Pain—Bleomycin—skin cancer	0.000211	0.00234	CcSEcCtD
Mexiletine—Leukopenia—Fluorouracil—skin cancer	0.000211	0.00234	CcSEcCtD
Mexiletine—Confusional state—Temozolomide—skin cancer	0.00021	0.00233	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00021	0.00233	CcSEcCtD
Mexiletine—Oedema—Temozolomide—skin cancer	0.000208	0.00231	CcSEcCtD
Mexiletine—Nausea—Imiquimod—skin cancer	0.000207	0.00229	CcSEcCtD
Mexiletine—Thrombocytopenia—Temozolomide—skin cancer	0.000204	0.00226	CcSEcCtD
Mexiletine—Convulsion—Fluorouracil—skin cancer	0.000204	0.00226	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—NRAS—skin cancer	0.000204	0.0153	CbGpPWpGaD
Mexiletine—Feeling abnormal—Bleomycin—skin cancer	0.000204	0.00226	CcSEcCtD
Mexiletine—Agranulocytosis—Docetaxel—skin cancer	0.000203	0.00225	CcSEcCtD
Mexiletine—Hyperhidrosis—Temozolomide—skin cancer	0.000201	0.00223	CcSEcCtD
Mexiletine—Chest pain—Fluorouracil—skin cancer	0.0002	0.00222	CcSEcCtD
Mexiletine—Fatigue—Dactinomycin—skin cancer	0.000199	0.0022	CcSEcCtD
Mexiletine—Discomfort—Fluorouracil—skin cancer	0.000198	0.00219	CcSEcCtD
Mexiletine—Pain—Dactinomycin—skin cancer	0.000197	0.00219	CcSEcCtD
Mexiletine—Body temperature increased—Bleomycin—skin cancer	0.000195	0.00217	CcSEcCtD
Mexiletine—Hepatitis—Docetaxel—skin cancer	0.000195	0.00216	CcSEcCtD
Mexiletine—Hypoaesthesia—Docetaxel—skin cancer	0.000194	0.00215	CcSEcCtD
Mexiletine—Confusional state—Fluorouracil—skin cancer	0.000194	0.00215	CcSEcCtD
Mexiletine—Pharyngitis—Docetaxel—skin cancer	0.000194	0.00215	CcSEcCtD
Mexiletine—Oedema—Fluorouracil—skin cancer	0.000192	0.00213	CcSEcCtD
Mexiletine—Feeling abnormal—Dactinomycin—skin cancer	0.00019	0.00211	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00019	0.00211	CcSEcCtD
Mexiletine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000188	0.00209	CcSEcCtD
Mexiletine—Thrombocytopenia—Fluorouracil—skin cancer	0.000188	0.00208	CcSEcCtD
Mexiletine—Visual impairment—Docetaxel—skin cancer	0.000188	0.00208	CcSEcCtD
Mexiletine—Paraesthesia—Temozolomide—skin cancer	0.000187	0.00208	CcSEcCtD
Mexiletine—Dyspnoea—Temozolomide—skin cancer	0.000186	0.00206	CcSEcCtD
Mexiletine—Somnolence—Temozolomide—skin cancer	0.000185	0.00205	CcSEcCtD
Mexiletine—Erythema multiforme—Docetaxel—skin cancer	0.000184	0.00205	CcSEcCtD
Mexiletine—Dyspepsia—Temozolomide—skin cancer	0.000183	0.00203	CcSEcCtD
Mexiletine—SCN9A—Axon guidance—SCN10A—skin cancer	0.000183	0.0137	CbGpPWpGaD
Mexiletine—Body temperature increased—Dactinomycin—skin cancer	0.000182	0.00202	CcSEcCtD
Mexiletine—Abdominal pain—Dactinomycin—skin cancer	0.000182	0.00202	CcSEcCtD
Mexiletine—Hypersensitivity—Bleomycin—skin cancer	0.000182	0.00202	CcSEcCtD
Mexiletine—Fatigue—Temozolomide—skin cancer	0.00018	0.00199	CcSEcCtD
Mexiletine—Hypotension—Fluorouracil—skin cancer	0.000179	0.00199	CcSEcCtD
Mexiletine—Pain—Temozolomide—skin cancer	0.000178	0.00198	CcSEcCtD
Mexiletine—Constipation—Temozolomide—skin cancer	0.000178	0.00198	CcSEcCtD
Mexiletine—Asthenia—Bleomycin—skin cancer	0.000177	0.00197	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—KRAS—skin cancer	0.000175	0.0132	CbGpPWpGaD
Mexiletine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000175	0.00194	CcSEcCtD
Mexiletine—Arrhythmia—Docetaxel—skin cancer	0.000174	0.00193	CcSEcCtD
Mexiletine—Paraesthesia—Fluorouracil—skin cancer	0.000172	0.00191	CcSEcCtD
Mexiletine—Alopecia—Docetaxel—skin cancer	0.000172	0.00191	CcSEcCtD
Mexiletine—Feeling abnormal—Temozolomide—skin cancer	0.000172	0.0019	CcSEcCtD
Mexiletine—Dyspnoea—Fluorouracil—skin cancer	0.000171	0.0019	CcSEcCtD
Mexiletine—Somnolence—Fluorouracil—skin cancer	0.000171	0.00189	CcSEcCtD
Mexiletine—Gastrointestinal pain—Temozolomide—skin cancer	0.00017	0.00189	CcSEcCtD
Mexiletine—Hypersensitivity—Dactinomycin—skin cancer	0.00017	0.00188	CcSEcCtD
Mexiletine—Dyspepsia—Fluorouracil—skin cancer	0.000169	0.00187	CcSEcCtD
Mexiletine—SCN4A—Axon guidance—SCN10A—skin cancer	0.000168	0.0126	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—SCN10A—skin cancer	0.000168	0.0126	CbGpPWpGaD
Mexiletine—Dysgeusia—Docetaxel—skin cancer	0.000166	0.00184	CcSEcCtD
Mexiletine—Asthenia—Dactinomycin—skin cancer	0.000165	0.00183	CcSEcCtD
Mexiletine—Abdominal pain—Temozolomide—skin cancer	0.000165	0.00183	CcSEcCtD
Mexiletine—Body temperature increased—Temozolomide—skin cancer	0.000165	0.00183	CcSEcCtD
Mexiletine—Pain—Fluorouracil—skin cancer	0.000164	0.00182	CcSEcCtD
Mexiletine—Muscle spasms—Docetaxel—skin cancer	0.000163	0.00181	CcSEcCtD
Mexiletine—Feeling abnormal—Fluorouracil—skin cancer	0.000158	0.00175	CcSEcCtD
Mexiletine—Diarrhoea—Dactinomycin—skin cancer	0.000158	0.00175	CcSEcCtD
Mexiletine—Vomiting—Bleomycin—skin cancer	0.000157	0.00174	CcSEcCtD
Mexiletine—Rash—Bleomycin—skin cancer	0.000156	0.00173	CcSEcCtD
Mexiletine—Dermatitis—Bleomycin—skin cancer	0.000156	0.00173	CcSEcCtD
Mexiletine—Hypersensitivity—Temozolomide—skin cancer	0.000154	0.0017	CcSEcCtD
Mexiletine—Syncope—Docetaxel—skin cancer	0.000152	0.00169	CcSEcCtD
Mexiletine—Leukopenia—Docetaxel—skin cancer	0.000152	0.00169	CcSEcCtD
Mexiletine—Body temperature increased—Fluorouracil—skin cancer	0.000152	0.00168	CcSEcCtD
Mexiletine—Palpitations—Docetaxel—skin cancer	0.00015	0.00166	CcSEcCtD
Mexiletine—Asthenia—Temozolomide—skin cancer	0.00015	0.00166	CcSEcCtD
Mexiletine—Loss of consciousness—Docetaxel—skin cancer	0.000149	0.00166	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—HRAS—skin cancer	0.000149	0.0112	CbGpPWpGaD
Mexiletine—Convulsion—Docetaxel—skin cancer	0.000147	0.00163	CcSEcCtD
Mexiletine—Nausea—Bleomycin—skin cancer	0.000147	0.00163	CcSEcCtD
Mexiletine—Hypertension—Docetaxel—skin cancer	0.000147	0.00163	CcSEcCtD
Mexiletine—Vomiting—Dactinomycin—skin cancer	0.000147	0.00162	CcSEcCtD
Mexiletine—Rash—Dactinomycin—skin cancer	0.000145	0.00161	CcSEcCtD
Mexiletine—Arthralgia—Docetaxel—skin cancer	0.000145	0.0016	CcSEcCtD
Mexiletine—Chest pain—Docetaxel—skin cancer	0.000145	0.0016	CcSEcCtD
Mexiletine—Diarrhoea—Temozolomide—skin cancer	0.000143	0.00158	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CDK4—skin cancer	0.000142	0.0106	CbGpPWpGaD
Mexiletine—Hypersensitivity—Fluorouracil—skin cancer	0.000141	0.00157	CcSEcCtD
Mexiletine—Dry mouth—Docetaxel—skin cancer	0.000141	0.00157	CcSEcCtD
Mexiletine—Confusional state—Docetaxel—skin cancer	0.00014	0.00155	CcSEcCtD
Mexiletine—Oedema—Docetaxel—skin cancer	0.000139	0.00154	CcSEcCtD
Mexiletine—Dizziness—Temozolomide—skin cancer	0.000138	0.00153	CcSEcCtD
Mexiletine—Nausea—Dactinomycin—skin cancer	0.000137	0.00152	CcSEcCtD
Mexiletine—Shock—Docetaxel—skin cancer	0.000136	0.00151	CcSEcCtD
Mexiletine—Thrombocytopenia—Docetaxel—skin cancer	0.000136	0.0015	CcSEcCtD
Mexiletine—Vomiting—Temozolomide—skin cancer	0.000133	0.00147	CcSEcCtD
Mexiletine—Rash—Temozolomide—skin cancer	0.000131	0.00146	CcSEcCtD
Mexiletine—Diarrhoea—Fluorouracil—skin cancer	0.000131	0.00146	CcSEcCtD
Mexiletine—Dermatitis—Temozolomide—skin cancer	0.000131	0.00146	CcSEcCtD
Mexiletine—Headache—Temozolomide—skin cancer	0.000131	0.00145	CcSEcCtD
Mexiletine—SCN9A—Developmental Biology—SCN10A—skin cancer	0.000131	0.0098	CbGpPWpGaD
Mexiletine—Hypotension—Docetaxel—skin cancer	0.00013	0.00144	CcSEcCtD
Mexiletine—Dizziness—Fluorouracil—skin cancer	0.000127	0.00141	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000126	0.0014	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—BRAF—skin cancer	0.000125	0.00941	CbGpPWpGaD
Mexiletine—Paraesthesia—Docetaxel—skin cancer	0.000124	0.00138	CcSEcCtD
Mexiletine—Nausea—Temozolomide—skin cancer	0.000124	0.00137	CcSEcCtD
Mexiletine—Dyspnoea—Docetaxel—skin cancer	0.000124	0.00137	CcSEcCtD
Mexiletine—Somnolence—Docetaxel—skin cancer	0.000123	0.00137	CcSEcCtD
Mexiletine—Vomiting—Fluorouracil—skin cancer	0.000122	0.00135	CcSEcCtD
Mexiletine—Dyspepsia—Docetaxel—skin cancer	0.000122	0.00135	CcSEcCtD
Mexiletine—Rash—Fluorouracil—skin cancer	0.000121	0.00134	CcSEcCtD
Mexiletine—Dermatitis—Fluorouracil—skin cancer	0.000121	0.00134	CcSEcCtD
Mexiletine—Headache—Fluorouracil—skin cancer	0.00012	0.00133	CcSEcCtD
Mexiletine—SCN2A—Developmental Biology—SCN10A—skin cancer	0.00012	0.00901	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—SCN10A—skin cancer	0.00012	0.00901	CbGpPWpGaD
Mexiletine—Fatigue—Docetaxel—skin cancer	0.000119	0.00133	CcSEcCtD
Mexiletine—Pain—Docetaxel—skin cancer	0.000119	0.00131	CcSEcCtD
Mexiletine—Constipation—Docetaxel—skin cancer	0.000119	0.00131	CcSEcCtD
Mexiletine—Feeling abnormal—Docetaxel—skin cancer	0.000114	0.00127	CcSEcCtD
Mexiletine—Nausea—Fluorouracil—skin cancer	0.000114	0.00126	CcSEcCtD
Mexiletine—SCN5A—Axon guidance—SCN10A—skin cancer	0.000114	0.00856	CbGpPWpGaD
Mexiletine—Gastrointestinal pain—Docetaxel—skin cancer	0.000113	0.00126	CcSEcCtD
Mexiletine—AHR—Circadian rythm related genes—CDK4—skin cancer	0.000113	0.00846	CbGpPWpGaD
Mexiletine—Abdominal pain—Docetaxel—skin cancer	0.00011	0.00121	CcSEcCtD
Mexiletine—Body temperature increased—Docetaxel—skin cancer	0.00011	0.00121	CcSEcCtD
Mexiletine—SCN9A—Axon guidance—RASA1—skin cancer	0.000105	0.00789	CbGpPWpGaD
Mexiletine—Hypersensitivity—Docetaxel—skin cancer	0.000102	0.00113	CcSEcCtD
Mexiletine—Asthenia—Docetaxel—skin cancer	9.94e-05	0.0011	CcSEcCtD
Mexiletine—SCN2A—Axon guidance—RASA1—skin cancer	9.65e-05	0.00725	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—RASA1—skin cancer	9.65e-05	0.00725	CbGpPWpGaD
Mexiletine—Diarrhoea—Docetaxel—skin cancer	9.48e-05	0.00105	CcSEcCtD
Mexiletine—SCN10A—Axon guidance—RASA1—skin cancer	9.31e-05	0.00699	CbGpPWpGaD
Mexiletine—Dizziness—Docetaxel—skin cancer	9.16e-05	0.00102	CcSEcCtD
Mexiletine—Vomiting—Docetaxel—skin cancer	8.81e-05	0.000977	CcSEcCtD
Mexiletine—Rash—Docetaxel—skin cancer	8.74e-05	0.000969	CcSEcCtD
Mexiletine—Dermatitis—Docetaxel—skin cancer	8.73e-05	0.000968	CcSEcCtD
Mexiletine—Headache—Docetaxel—skin cancer	8.68e-05	0.000963	CcSEcCtD
Mexiletine—Nausea—Docetaxel—skin cancer	8.23e-05	0.000913	CcSEcCtD
Mexiletine—SCN5A—Developmental Biology—SCN10A—skin cancer	8.13e-05	0.00611	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—RASA1—skin cancer	7.5e-05	0.00563	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—RASA1—skin cancer	6.89e-05	0.00517	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—RASA1—skin cancer	6.89e-05	0.00517	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—KRAS—skin cancer	6.78e-05	0.00509	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—RASA1—skin cancer	6.64e-05	0.00499	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—RASA1—skin cancer	6.54e-05	0.00491	CbGpPWpGaD
Mexiletine—AHR—Adipogenesis—IL6—skin cancer	6.21e-05	0.00467	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—TP53—skin cancer	6.02e-05	0.00452	CbGpPWpGaD
Mexiletine—AHR—Circadian rythm related genes—TP53—skin cancer	4.79e-05	0.0036	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—RASA1—skin cancer	4.67e-05	0.00351	CbGpPWpGaD
Mexiletine—AHR—Circadian rythm related genes—IL6—skin cancer	4.39e-05	0.00329	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—CDK4—skin cancer	3.68e-05	0.00276	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—CDK4—skin cancer	3.38e-05	0.00254	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—CDK4—skin cancer	3.38e-05	0.00254	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—CDK4—skin cancer	3.26e-05	0.00245	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	2.88e-05	0.00217	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—NRAS—skin cancer	2.86e-05	0.00215	CbGpPWpGaD
Mexiletine—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	2.7e-05	0.00203	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—NRAS—skin cancer	2.63e-05	0.00198	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—NRAS—skin cancer	2.63e-05	0.00198	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—NRAS—skin cancer	2.54e-05	0.00191	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—KRAS—skin cancer	2.47e-05	0.00185	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—CDK4—skin cancer	2.29e-05	0.00172	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—KRAS—skin cancer	2.27e-05	0.0017	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—KRAS—skin cancer	2.27e-05	0.0017	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	2.24e-05	0.00169	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—IL6—skin cancer	2.24e-05	0.00168	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—KRAS—skin cancer	2.18e-05	0.00164	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—HRAS—skin cancer	2.1e-05	0.00157	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—NRAS—skin cancer	2.04e-05	0.00154	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.02e-05	0.00152	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—IL6—skin cancer	2.01e-05	0.00151	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	1.93e-05	0.00145	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—HRAS—skin cancer	1.93e-05	0.00145	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—HRAS—skin cancer	1.93e-05	0.00145	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—NRAS—skin cancer	1.88e-05	0.00141	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—NRAS—skin cancer	1.88e-05	0.00141	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—HRAS—skin cancer	1.86e-05	0.00139	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—IL6—skin cancer	1.84e-05	0.00138	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—IL6—skin cancer	1.84e-05	0.00138	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—NRAS—skin cancer	1.81e-05	0.00136	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—NRAS—skin cancer	1.78e-05	0.00134	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—IL6—skin cancer	1.78e-05	0.00133	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—KRAS—skin cancer	1.76e-05	0.00132	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.64e-05	0.00123	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—KRAS—skin cancer	1.62e-05	0.00121	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—KRAS—skin cancer	1.62e-05	0.00121	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—KRAS—skin cancer	1.56e-05	0.00117	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—KRAS—skin cancer	1.54e-05	0.00115	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PLIN2—skin cancer	1.53e-05	0.00115	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PLIN2—skin cancer	1.5e-05	0.00112	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—HRAS—skin cancer	1.5e-05	0.00112	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—IL6—skin cancer	1.43e-05	0.00107	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—HRAS—skin cancer	1.37e-05	0.00103	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—HRAS—skin cancer	1.37e-05	0.00103	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—HRAS—skin cancer	1.33e-05	0.000995	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—IL6—skin cancer	1.32e-05	0.000988	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—IL6—skin cancer	1.32e-05	0.000988	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—HRAS—skin cancer	1.31e-05	0.00098	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—NRAS—skin cancer	1.27e-05	0.000956	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—IL6—skin cancer	1.27e-05	0.000952	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—IL6—skin cancer	1.25e-05	0.000938	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CSPG4—skin cancer	1.23e-05	0.000925	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CSPG4—skin cancer	1.21e-05	0.000906	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—KRAS—skin cancer	1.1e-05	0.000823	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PLIN2—skin cancer	1.06e-05	0.000798	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—HRAS—skin cancer	9.32e-06	0.0007	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PLIN2—skin cancer	9e-06	0.000676	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—IL6—skin cancer	8.92e-06	0.00067	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CSPG4—skin cancer	8.56e-06	0.000643	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ENO2—skin cancer	8.38e-06	0.000629	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ENO2—skin cancer	8.2e-06	0.000616	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CSPG4—skin cancer	7.25e-06	0.000545	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PLIN2—skin cancer	6.95e-06	0.000522	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ENO2—skin cancer	5.82e-06	0.000437	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CSPG4—skin cancer	5.6e-06	0.00042	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ENO2—skin cancer	4.93e-06	0.00037	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ERCC2—skin cancer	4.86e-06	0.000365	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ERCC2—skin cancer	4.76e-06	0.000358	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.86e-06	0.00029	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ENO2—skin cancer	3.81e-06	0.000286	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ERCC2—skin cancer	3.38e-06	0.000254	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PTGS2—skin cancer	2.92e-06	0.000219	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ERCC2—skin cancer	2.86e-06	0.000215	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PTGS2—skin cancer	2.86e-06	0.000215	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ERCC2—skin cancer	2.21e-06	0.000166	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PTGS2—skin cancer	2.03e-06	0.000152	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PTGS2—skin cancer	1.72e-06	0.000129	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PTGS2—skin cancer	1.33e-06	9.95e-05	CbGpPWpGaD
